Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,539.2
23.5 (0.93%)

 

  • STI Straits Times Index
    2,539.2
    23.5 (0.93%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,576.8
    0.9 (0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,006.1
    59.5 (0.24%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,373.9
    2.2 (0.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,114.3
    39.3 (0.77%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 977.8M
  • Value: 874.4M
  • Rise: 212
  • Fall: 95
  • Unch: 501

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.187+0.004
AnAn Intl0.042+0.007
Synagie0.197+0.008
Leader Env0.066+0.010
LionGold0.002-
Medtecs Intl1.030+0.045
Anchor Resources0.009+0.002
Genting Sing0.715-0.015
CNMC Goldmine0.350+0.040
Sembcorp Marine0.390+0.050

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PFIZER INC PFIZER
Updated on 04 Aug 2020 (End of trading day)
Last (USD): 38.390 Change: +0.040 High: 38.680 Remarks: -
Change (%): +0.10 Low: 38.090
Open 38.310 Yesterday's Close 38.35
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 27,822,420 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 2.92934 Trailing EPS (USD) e 2.55093 NAV (USD) b -
PE a 13.105 Trailing PE f 15.049 Price / NAV b -
Dividend (USD) d 1.454525 Cash In Hand (USD) g - Issued & Paid-up Shares c 5,554,830,000
Dividend Yield (%) d 3.789 Price / Cash In Hand g - Treasury Shares h 3,841,000,000
Market Cap (M) 213,249.924 Enterprise Value (M) 213,249.924
Piotroski F Score 6 Exchange Code PFE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 29.27 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 May 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PFIZER INC NYSE 213,249.924 13.105 15.049 - 3.789
Industry Pharmaceuticals: Major NYSE 118,728.196 24.901 26.326 8.0936 1.916
Local Peer JOHNSON & JOHNSON NYSE 387,603.760 25.637 25.525 6.1546 2.547
Local Peer MERCK & CO INC NYSE 206,143.247 20.943 19.672 - 2.784
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 207,603.099 29.455 28.761 3.8580 2.189
Local Peer ABBVIE INC NYSE 166,171.039 21.190 24.013 - 3.907
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 147,184.203 109.795 96.563 13.6561 2.443
Local Peer ELI LILLY AND COMPANY NYSE 148,109.380 31.935 26.379 36.2087 1.667
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 134,562.174 39.128 141.050 2.6960 2.782
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,145.753 20.062 19.496 14.6454 1.759
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 103,456.314 17.459 21.449 - 4.730
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 57,916.569 142.337 142.335 1.3237 -
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 3,880.685 - - 31.8199 -
Local Peer ADC THERAPEUTICS SA NYSE 3,462.926 - - 31.1530 -
Other Local Peers ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,400.487 40.078 40.078 1.9712 2.257
Global Peer WUXI APPTEC HKEx 283,630.743 135.113 142.007 14.6225 0.212
Global Peer ROYALTY PHARMA PLC NASDAQ 26,223.912 11.166 11.166 5.0822 -
Global Peer HANSOH PHARMA HKEx 192,663.125 66.456 66.455 13.2038 -
Global Peer INNOVENT BIO HKEx 72,086.095 - - 13.5494 -
Global Peer REPLIGEN CORP NASDAQ 8,218.757 383.855 265.644 7.4714 -
Global Peer SINOPHARM HKEx 60,065.342 8.474 8.474 1.1323 3.241
Global Peer CANSINOBIO-B HKEx 56,909.340 - - - -
Global Peer JUNSHI BIO HKEx 46,308.373 - - 15.3773 -
Global Peer SH PHARMA HKEx 45,132.437 9.753 9.753 0.9685 3.029
Other Global Peers BAIYUNSHAN PH (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), HENLIUS-B (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALLAKOS INC (NASDAQ), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), OPKO HEALTH INC (NASDAQ), CMS (HKEx), AKESO-B (HKEx), HEPALINK (HKEx), HYGEIA HEALTH (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), TRAD CHI MED (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), INNOCARE-B (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), OCUMENSION-B (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), SSY GROUP (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), UNITED LAB (HKEx), IGM BIOSCIENCES INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CSTONE PHARMA-B (HKEx), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), CKLIFE SCIENCES (HKEx), AKERO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), TONGRENTANGCM (HKEx), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ATHENEX INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), HUA MEDICINE-B (HKEx), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), Kimia Farma Tbk. (IDX), KRYSTAL BIOTECH INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ANNEXON INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), IMMUNOTECH-B (HKEx), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), IGBB (Bursa), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SHINEWAY PHARM (HKEx), KALA PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), INOZYME PHARMA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), TOT BIOPHARM-B (HKEx), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), FUSEN PHARM (HKEx), IMMUNIC INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), IDEAYA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), BSTEAD (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), PHARMA (Bursa), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), POLYPID LTD (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), LIQUIDIA TECHNOLOGIES INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), CH BIOTECH SER (HKEx), SCPHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), DAWNRAYS PHARMA (HKEx), AYALA PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), ZHONGZHIPHARM (HKEx), PROTARA THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), GENPREX INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), IX Biopharma (SGX), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), Hyphens Pharma (SGX), CHECKPOINT THERAPEUTICS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), CORVUS PHARMACEUTICALS INC (NASDAQ), BIOMX INC (NYSE American), APTORUM GROUP LIMITED (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), Merck Tbk. (IDX), KOTRA (Bursa), NOVAN INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), MEDIWOUND LTD (NASDAQ), EVOLUS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), NEW RAY MEDIC (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), NOVA (Bursa), Phapros Tbk. (IDX), CLEARSIDE BIOMEDICAL INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), PALLA PHARMA LTD (ASX), TREVI THERAPEUTICS INC (NASDAQ), PAK FAH YEOW (HKEx), RACE ONCOLOGY LTD (ASX), EYENOVIA INC (NASDAQ), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NC HEALTHCARE (HKEx), IP (SET), MOLECULIN BIOTECH INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BAUDAX BIO INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ARIDIS PHARMACEUTICAL INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), IMMURON LIMITED (ASX), CITIUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), NEP INTERLONG (HKEx), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), NOXOPHARM LTD (ASX), MANNATECH INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), ACER THERAPEUTICS INC (NASDAQ), ANNOVIS BIO INC (NYSE American), HOTH THERAPEUTICS INC (NASDAQ), SANAI HEALTH GP (HKEx), AILERON THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), JCT (SET), HISTOGEN INC (NASDAQ), PURAPHARM (HKEx), INVION LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), EXTRAWELL PHAR (HKEx), TITAN PHARMACEUTICAL INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), PHARMAXIS (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), ADIAL PHARMACEUTICALS INC (NASDAQ), SUNZEN (Bursa), PROPHASE LABS INC (NASDAQ), ACRUX (ASX), PASHUN INT'L (HKEx), EXOPHARM LTD (ASX), SINOLIFE UTD (HKEx), TALI DIGITAL LIMITED (ASX), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), NOVUS THERAPEUTICS INC (NASDAQ), FIJI KAVA LTD (ASX), Pharmesis Intl (SGX), FARMAFORCE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.870
-2.22 %
10 Days --0.170
-0.44 %
20 Days -+4.640
+13.75 %
Medium Term Return 3 Months 0.380-0.120
+0.68 %
6 Months 0.380+0.220
+1.57 %
1 Year 1.120+1.810
+8.01 %
Long Term Return 2 Years 2.540-3.020
-1.16 %
3 Years 3.880+4.940
+26.37 %
5 Years 6.320+3.020
+26.41 %
Annualised Return Annualised --
+4.80 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 27.880 - 40.970 Change From 1 Year Low +10.510 % Change From 1 Year Low (%) +37.70
Change From 1 Year High -2.580 % Change From 1 Year High (%) -6.30
2 Years Range 27.880 - 46.470 Change From 2 Years Low +10.510 % Change From 2 Years Low (%) +37.70
Change From 2 Years High -8.080 % Change From 2 Years High (%) -17.39
5 Years Range 27.880 - 46.470 Change From 5 Years Low +10.510 % Change From 5 Years Low (%) +37.70
Change From 5 Years High -8.080 % Change From 5 Years High (%) -17.39
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Aug 2020 38.310 38.680 38.090 38.390 27,822,420 -
03 Aug 2020 38.610 38.660 38.215 38.350 29,413,920 -
31 Jul 2020 38.670 38.750 37.860 38.480 27,004,530 -
30 Jul 2020 38.280 38.940 38.201 38.740 30,571,530 -
29 Jul 2020 39.300 39.450 38.450 39.260 35,075,810 -
28 Jul 2020 38.540 39.335 38.060 39.020 53,339,110 -
27 Jul 2020 37.360 37.750 37.230 37.540 25,940,620 -
24 Jul 2020 38.030 38.150 37.325 37.660 31,889,520 -
23 Jul 2020 39.230 39.420 38.180 38.410 56,485,860 -
22 Jul 2020 38.230 38.730 37.520 38.560 85,372,230 -
21 Jul 2020 36.940 37.079 36.520 36.690 22,368,880 -
20 Jul 2020 37.490 37.620 36.320 36.500 34,769,040 -
17 Jul 2020 35.860 36.330 35.725 36.250 22,141,960 -
16 Jul 2020 35.600 35.640 35.255 35.600 17,466,280 -
15 Jul 2020 35.990 36.000 35.470 35.720 24,929,260 -
14 Jul 2020 35.370 35.420 34.880 35.230 31,038,800 -
13 Jul 2020 34.730 35.720 34.520 35.210 53,578,480 -
10 Jul 2020 33.660 34.040 33.485 33.830 23,189,770 -
09 Jul 2020 33.730 33.880 33.101 33.460 19,299,540 -
08 Jul 2020 34.010 34.370 33.570 33.750 22,999,920 -
07 Jul 2020 34.050 34.350 33.955 34.030 23,844,550 -
06 Jul 2020 34.950 34.990 34.380 34.510 25,736,550 -
Summary
Current 2 Weeks
(22 Jul 2020 to 04 Aug 2020)
38.230 39.450 37.230 38.390 402,915,550 -
Previous 2 Weeks
(08 Jul 2020 to 21 Jul 2020)
34.010 39.450 33.570 36.690 271,781,930 -
4 Weeks from
(09 Jun 2020 to 07 Jul 2020)
36.500 39.450 36.170 34.030 691,367,930 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.